DHB — Delivra Health Brands Share Price
0.000.00%
Last trade - 00:00- CA$5.63m
- CA$3.93m
- CA$12.38m
- 62
- 84
- 39
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | 1.51 | ||
| Price to Free Cashflow | 13.83 | ||
| Price to Sales | 0.45 | ||
| EV to EBITDA | 2.56 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.71% | ||
| Return on Equity | 0.15% | ||
| Operating Margin | 1.84% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 7.78 | 7.96 | 8.14 | 9.79 | 12.38 | 12.99 | 14.81 | 15.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 28th, 2008
- Public Since
- February 2nd, 2010
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 31,261,781
- Address
- Suite 404, 999 Canada Place, VANCOUVER, V6C 3E2
- Web
- https://www.delivrahealthbrands.com/
- Phone
- +1 6044499280
- Contact
- Jack Tasse
- Auditors
- Davidson & Co LLP
Upcoming Events for DHB
Q3 2025 Delivra Health Brands Inc Earnings Release
Q4 2025 Delivra Health Brands Inc Earnings Release
Similar to DHB
Aequus Pharmaceuticals
TSX Venture Exchange
Arch Biopartners
TSX Venture Exchange
Biosyent
TSX Venture Exchange
Cytophage Technologies
TSX Venture Exchange
Decibel Cannabis
TSX Venture Exchange
FAQ
What is the Delivra Health Brands share price?
As of Today at 20:12 UTC, shares in Delivra Health Brands are trading at CA$0.18. This share price information is delayed by 15 minutes.
How has the Delivra Health Brands share price performed this year?
Shares in Delivra Health Brands last closed at CA$0.18 and the price had moved by -55% over the past 365 days. In terms of relative price strength the Delivra Health Brands share price has underperformed the Toronto Stock Exchange 300 Composite Index by -59.99% over the past year.
What are the analyst and broker recommendations for Delivra Health Brands?
The overall consensus recommendation for Delivra Health Brands is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Delivra Health Brands dividend yield?
Delivra Health Brands does not currently pay a dividend.
Does Delivra Health Brands pay a dividend?
Delivra Health Brands does not currently pay a dividend.
When does Delivra Health Brands next pay dividends?
Delivra Health Brands does not currently pay a dividend.
How do I buy Delivra Health Brands shares?
To buy shares in Delivra Health Brands you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Delivra Health Brands?
As of the previous close price of CA$0.18, shares in Delivra Health Brands had a market capitalisation of CA$5.63m.
Where are Delivra Health Brands shares listed?
Here are the trading details for Delivra Health Brands:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: DHB
What kind of share is Delivra Health Brands?
Based on an overall assessment of its quality, value and momentum Delivra Health Brands is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Delivra Health Brands share price forecast for 2025?
The analyst consensus target price for shares in Delivra Health Brands is CA$0.74. That is 311.11% above the last closing price of CA$0.18.
Analysts covering Delivra Health Brands currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.03 for the next financial year.
Find out moreWhat is the trend in the Delivra Health Brands share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Delivra Health Brands. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -10.53%.
As of the last closing price of CA$0.18, shares in Delivra Health Brands were trading -15.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Delivra Health Brands PE Ratio?
The Delivra Health Brands PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Delivra Health Brands?
Delivra Health Brands' management team is headed by:
- Frank Holler - CHM
- Gord Davey - PRE
- Andrew Bayfield - DRC
- Peter Wall - DRC
- Jason Bednar - NID